140 related articles for article (PubMed ID: 38110823)
1. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
McCluggage WG
Histopathology; 2024 Jan; 84(2):288-290. PubMed ID: 38110823
[No Abstract] [Full Text] [Related]
2. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract][Full Text] [Related]
3. BRAF T1799A mutation occurring in a case of malignant struma ovarii.
Flavin R; Smyth P; Crotty P; Finn S; Cahill S; Denning K; Jinghuan Li ; O'Regan E; O'Leary J; Sheils O
Int J Surg Pathol; 2007 Apr; 15(2):116-20. PubMed ID: 17478764
[TBL] [Abstract][Full Text] [Related]
4. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
[TBL] [Abstract][Full Text] [Related]
5. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.
Coyne C; Nikiforov YE
Endocr Pathol; 2010 Jun; 21(2):144-7. PubMed ID: 19898969
[TBL] [Abstract][Full Text] [Related]
6. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
Poli R; Scatolini M; Grosso E; Maletta F; Gallo M; Liscia D; Nelva A; Cesario F; Forte G; Metovic J; Volante M; Arvat E; Papotti M
Endocrine; 2021 Jan; 71(1):216-224. PubMed ID: 32743766
[TBL] [Abstract][Full Text] [Related]
7. BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
Schmidt J; Derr V; Heinrich MC; Crum CP; Fletcher JA; Corless CL; Nosé V
Am J Surg Pathol; 2007 Sep; 31(9):1337-43. PubMed ID: 17721188
[TBL] [Abstract][Full Text] [Related]
8. Malignant struma ovarii. A case report and review of the literature.
Berghella V; Ngadiman S; Rosenberg H; Hoda S; Zuna RE
Gynecol Obstet Invest; 1997; 43(1):68-72. PubMed ID: 9015705
[TBL] [Abstract][Full Text] [Related]
9. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.
Seo GT; Minkowitz J; Kapustin DA; Fan J; Minkowitz G; Minkowitz M; Dowling E; Matloob A; Asti D; Dhar M; Shutty C; Brickman A; Urken ML; Brandwein-Weber M; Finkelstein SD
Diagn Pathol; 2023 Apr; 18(1):47. PubMed ID: 37072862
[TBL] [Abstract][Full Text] [Related]
10. Follicular variant papillary thyroid carcinoma arising in struma ovarii.
Boutross-Tadross O; Saleh R; Asa SL
Endocr Pathol; 2007; 18(3):182-6. PubMed ID: 18058267
[TBL] [Abstract][Full Text] [Related]
11. Malignant struma ovarii.
de Graaff J; van Vliet MA; Misereé J
Eur J Obstet Gynecol Reprod Biol; 1983 Sep; 16(1):31-5. PubMed ID: 6628817
[TBL] [Abstract][Full Text] [Related]
12. Malignant struma ovarii. A case report and literature review.
Gould SF; Lopez RL; Speers WC
J Reprod Med; 1983 Jun; 28(6):415-9. PubMed ID: 6887150
[TBL] [Abstract][Full Text] [Related]
13. It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii.
Smith LP; Brubaker LW; Wolsky RJ
Surg Pathol Clin; 2023 Mar; 16(1):75-86. PubMed ID: 36739168
[TBL] [Abstract][Full Text] [Related]
14. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.
Devaney K; Snyder R; Norris HJ; Tavassoli FA
Int J Gynecol Pathol; 1993 Oct; 12(4):333-43. PubMed ID: 8253550
[TBL] [Abstract][Full Text] [Related]
15. Pathology of Struma Ovarii: A Report of 96 Cases.
Wei S; Baloch ZW; LiVolsi VA
Endocr Pathol; 2015 Dec; 26(4):342-8. PubMed ID: 26374222
[TBL] [Abstract][Full Text] [Related]
16. Incidental diagnosis of struma ovarii after thyroidectomy for thyroid cancer: functional imaging studies and follow-up.
Ghander C; Lussato D; Conte Devolx B; Mundler O; Taïeb D
Gynecol Oncol; 2006 Aug; 102(2):378-80. PubMed ID: 16516952
[TBL] [Abstract][Full Text] [Related]
17. Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.
Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Krstevski V; Radlovic P; Buta M; Rulic B; Todorovic L; Dimitrijevic B; Yamashita S
BMC Cancer; 2012 Jun; 12():224. PubMed ID: 22682753
[TBL] [Abstract][Full Text] [Related]
18. The lack of consensus in management of malignant struma ovarii.
González Aguilera B; Guerrero Vázquez R; Gros Herguido N; Sánchez Gallego F; Navarro González E
Gynecol Endocrinol; 2015 Apr; 31(4):258-9. PubMed ID: 25539066
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.
Anastasilakis AD; Ruggeri RM; Polyzos SA; Makras P; Molyva D; Campennì A; Gkiomisi A; Balaris C; Fotiadis PP; Tuccari G; Papachatzopoulos S
Metabolism; 2013 Oct; 62(10):1350-6. PubMed ID: 23806737
[TBL] [Abstract][Full Text] [Related]
20. Whole-Genome and Segmental Homozygosity Confirm Errors in Meiosis as Etiology of Struma Ovarii.
Henderson BB; Chaubey A; Roth LM; Robboy SJ; Tarasidis G; Jones JR; Sundermann JM; Chou J; Craddock AL; Stevenson L; Friez MJ; Kincaid EH; Stevenson RE
Cytogenet Genome Res; 2020; 160(1):2-10. PubMed ID: 31865307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]